Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanezumab vs NSAIDs in Osteoarthritis
NCT02528188Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jul 2015
- Primary completion
- Oct 2018
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 18
01
Overview
A Phase 3 trial of tanezumab in osteoarthritis (OA), sponsored by Pfizer. Started Jul 2015; status: completed.
02
Drugs
tanezumab
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02528188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02528188.